Publicaciones (29) Publicaciones de MARCELINO FERRER ALCÓN

2023

  1. Implication of the PTN/RPTPβ/ζ Signaling Pathway in Acute Ethanol Neuroinflammation in Both Sexes: A Comparative Study with LPS

    Biomedicines, Vol. 11, Núm. 5

2022

  1. Metabolomics and biochemical alterations caused by pleiotrophin in the 6-hydroxydopamine mouse model of Parkinson’s disease

    Scientific Reports, Vol. 12, Núm. 1

2020

  1. Role of RPTPβ/ζ in neuroinflammation and microglia-neuron communication

    Scientific Reports, Vol. 10, Núm. 1

2017

  1. Pleiotrophin regulates microglia-mediated neuroinflammation

    Journal of Neuroinflammation, Vol. 14, Núm. 1

2016

  1. Pleiotrophin overexpression regulates amphetamine-induced reward and striatal dopaminergic denervation without changing the expression of dopamine D1 and D2 receptors: Implications for neuroinflammation

    European Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 1794-1805

2015

  1. Chronic Cocaine Use Causes Changes in the Striatal Proteome Depending on the Endogenous Expression of Pleiotrophin

    Chemical Research in Toxicology, Vol. 28, Núm. 7, pp. 1443-1454

2014

  1. FADD adaptor and PEA-15/ERK1/2 partners in major depression and schizophrenia postmortem brains: Basal contents and effects of psychotropic treatments

    Neuroscience, Vol. 277, pp. 541-551

  2. Pleiotrophin differentially regulates the rewarding and sedative effects of ethanol

    Journal of Neurochemistry, Vol. 131, Núm. 5, pp. 688-695

2013

  1. Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia.

    Translational psychiatry, Vol. 3

2010

  1. Identification and validation of new innovative therapeutic targets in psychiatry

    European Journal of Clinical Pharmacology

2009

  1. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics

    Toxicology Letters, Vol. 186, Núm. 1, pp. 45-51

2008

  1. Gene expression patterns in brain cortex of three different animal models of depression

    Genes, Brain and Behavior, Vol. 7, Núm. 6, pp. 649-658

  2. Low intensity exercise attenuates disease progression and stimulates cell proliferation in the spinal cord of a mouse model with progressive motor neuronopathy

    Neuroscience, Vol. 152, Núm. 2, pp. 291-295

2007

  1. Effects of constitutive deletion of opioid receptors on the basal densities of Fas and Fas-associated protein with death domain (FADD) in the mouse brain: A δ-opioid tone inhibits FADD

    European Neuropsychopharmacology, Vol. 17, Núm. 5, pp. 366-374

  2. Grafted neural stem cells increase the life span and protect motoneurons in pmn mice

    NeuroReport, Vol. 18, Núm. 14, pp. 1463-1468

  3. The neuroprotective effects of the Wlds gene are correlated with proteasome expression rather than apoptosis

    European Journal of Neuroscience, Vol. 25, Núm. 8, pp. 2269-2274

2004

  1. Decreased immunodensities of μ-opioid receptors, receptor kinases GRK 2/6 and β-arrestin-2 in postmortem brains of opiate addicts

    Molecular Brain Research, Vol. 121, Núm. 1-2, pp. 114-122

  2. Deglycosylation of Fas receptor and chronic morphine treatment up-regulate high molecular mass Fas aggregates in the rat brain

    European Journal of Pharmacology, Vol. 496, Núm. 1-3, pp. 63-69

  3. Long-term regulation of signalling components of adenylyl cyclase and mitogen-activated protein kinase in the pre-frontal cortex of human opiate addicts

    Journal of Neurochemistry, Vol. 90, Núm. 1, pp. 220-230

  4. Motoneuron Resistance to Apoptotic Cell Death In Vivo Correlates with the Ratio between X-Linked Inhibitor of Apoptosis Proteins (XIAPs) and Its Inhibitor, XIAP-Associated Factor 1

    Journal of Neuroscience, Vol. 24, Núm. 15, pp. 3777-3785